Sunday, October 29, 2023

Ending Soon: Extra 50% Off Clearance πŸŽƒ

Offer Ends at Midnight ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­

ProTrader LIVE Trading this Monday @ 12 pm!

On Monday, October 30th @ 12 pm (the day after his birthday) Roger Scott is hosting the first ever ProTrader Dashboard LIVE Trading Session!
 
   
     
On Monday, October 30th @ 12 pm (the day after his birthday) Roger Scott is hosting the first ever ProTrader Dashboard LIVE Trading Session!*

*[Clicking this link will automatically register you for ProTrader Dashboard and periodic updates from The TradingPub (privacy policy)]

Not only do you get to look over his shoulder as he scans the market for hot new trade ideas… and take them as they come 100% FREE

But you’ll get to see how the brand new ProTrader Dashboard can instantly track the stocks that Wall Street traders are likely buying or selling… in real time! 

Just look at some of the past top signals so far…

69% on NEE in 1 day
75% on PENN in 2 days
80% on TSLA in 1 day
105% on SQ in 2 days
114% on SO in 1 day
220% on ORCL in 2 days
426% on RTX in 2 days
584% on DELL in 2 days

Granted, some trades were bigger, some were smaller and some even resulted in a loss. 

But overall, Roger has nailed some pretty sweet winners using the all-new ProTrader Dashboard

You can check out his free live trading session which is happening on Monday, October 30th at 12 p.m. ET…

But to prepare your mind for that, here’s a quick insider view of exactly what this tool is capable of… 

 
 

And once you view it, you’ll see how you can unlock a free pass to Roger’s upcoming trading session.

Check it out here for free


To Your Wealth, 

Garrett Baldwin 


*The profits and performance shown are not typical, we make no future earnings claims and you may lose money. The alerts expressed are trades Roger published in real time using the ProTrader Dashboard in his VIP room over the summer. There were bigger winners, there were smaller winners, and there were losers. Trade at your own risk. 
 
   
 

A Guide To This Week’s Earnings

 

What to Watch for This Week

Key Job’s Market Data Queued Up

On Wednesday, two important U.S. job market reports will be made available. In the morning, both the latest ADP employment & U.S. Job Openings reports will be revealed. The labor market has remained quite resilient in the face of the Fed rapidly raising their Fed Funds rate to tame inflation.Any sign from these reports that the labor market is beginning to soften, despite being negative economic news, would likely be welcomed news for the stock market as it could be a prelude to relief from high treasury yields.

  • ADP Employment Report – Before the market opens, on Wednesday morning investors will get the latest ADP employment report for the month of October. The ADP employment report measures the net change month-over-month in private employment in the U.S.
    • October’s job gains are forecasted to come in at 150,000, which is significantly higher than the previous month’s add of 89,000.  
  • Job Openings and Labor Turnover Summary (JOLTS) – The Bureau of Labor Statistics’ September JOLTS report will follow the ADP report and will be released shortly after the market opens. The JOLTS report tracks the number of job openings & various metrics on the number of workers who left the workplace during the respective period.
    • September’s job openings are expected to come in at 9.3 million, a month-over-month decrease of 3.1%.

Federal Reserve Decision

On Wednesday, investors will finally get the Fed’s next policy decision as the upcoming FOMC meeting will conclude. Possibly even more important than this meeting’s policy decision will be Fed Chairman Powell’s tone and messaging regarding upcoming meetings and potential policy moves by the FOMC. His messaging regarding future hikes to the Fed Funds rate or any potential plans to cut will have market watchers tuned in. 

  • Currently, Fed Funds Futures indicate that investors believe that the Fed’s policy rate will remain paused through the end of the year. Additionally, the CME Group projects a 99.9% probability that at this week’s FOMC meeting the committee will opt to maintain the current target range between 5.25%-5.50%. However, for the meeting set to take place in mid-December, the CME Group places a 19.8% probability that the committee will opt to hike rates by 25 basis points. Investors will be looking for any clarity regarding the Fed’s next potential moves.

All About the Earnings

Following the most important earnings week of this season, there is no rest for the weary as there are a number of crucial companies set to deliver their Q3 results this week. On Thursday, investors will be tuned in to hear Q3 numbers from Apple Inc. Also, on deck this week are drug-makers Eli Lilly & Co. & Novo Nordisk. Finally, Advanced Micro Devices, Inc. & QUALCOMM Inc. are due to report their earnings during the middle of the week.  

  • In what will likely be the most pivotal earnings report this week for the broader market, Apple Inc. is set to report after market close on Thursday. AAPL shares currently account for over 7% of the entire weighting of the S&P 500 index. Their post earnings reaction is sure to have an effect on the broader markets.
    • AAPL earnings are expected to come in at $1.39 EPS.
  • Additionally on Thursday, prior to market open, we will get to see the Q3 results for both Eli Lilly & Co. & Novo Nordisk. Each of these companies have been standout strong points in the market this year, fueled by investors’ enthusiasm behind their new GLP-1 drugs. Wall St. will be anxiously awaiting to see if each of these companies can deliver on the recent hype.
    • LLY earnings are expected to come in at -$0.11 EPS.
    • NVO earnings are expected to come in at $0.60 EPS.
  • This week we will also hear from chipmakers, Advanced Micro Devices, Inc. & QUALCOMM Inc. as investors digest their earnings from the previous quarter. AMD is set up to report after the bell on Tuesday and QCOM will report the following day in aftermarket hours. QCOM earnings could potentially provide a read-through to AAPL earnings as QCOM is AAPL’s main supplier of iPhone chips.
    • AMD earnings are expected to come in at $0.49 EPS.
    • QCOM earnings are expected to come in at $1.45 EPS.

Thank you for reading this week’s edition of the Weekly Market Periscope Newsletter, I hope you enjoyed it. Please lookout out for the next edition of the newsletter as we will give you a preview of the upcoming week’s important market events.

Thanks,

Blane Markham

Author, Weekly Market Periscope

Hughes Optioneering Team


See Related Articles on TradewinsDaily.com

A Guide To This Week’s Earnings

Capitalize On Dominion’s Decline

TLT: Profit From the Bond Wreck?

This Jumped Nicely, Will It Go Higher?

Chart of the Day: Target (TGT)


TradeWins Logo
 

© 2023 Tradewins Publishing. All rights reserved. | Privacy Policy | Terms and Conditions | Contact Us

Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC's website: All About Auto-Trading, https://www.sec.gov/reportspubs/investor-publications/investorpubsautotradinghtm.html
TradeWins does not recommend or refer subscribers to broker-dealers. You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading.

1. The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the "Services") is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by TradeWins Publishing ("TradeWins") a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. The Services are intended to supplement your own research and analysis.

2. TradeWins' Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services.

3. Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services. No person subscribing for the Services ("Subscriber") should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber.

4. You should trade or invest only "risk capital" money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more.

5. All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities.

6. Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown.

7. No representation is being made that you will achieve profits or the same results as any person providing testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses.

8. The author experiences are not typical. The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber's own election and for the Subscriber's own risk.

You are currently subscribed to mwd as: stevenmagallanes520.nims@blogger.com.
Add support@marketwealthdaily.com to your email address book to ensure delivery.
Forward to a Friend | Manage Subscription | Subscribe | Unsubscribe | Snooze
                                 

they are calling this “Nature’s Morphine”

US Market Approval - No Side Effects or Addiction Risk

Page List

Blog Archive

Search This Blog

You’re In! Your Cash Code X LIVE Trading Masterclass access details

Cash Code X Live Trading Masterclass ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ...